WASHINGTON, D.C. [12/17/19]—U.S. Senators Tina Smith (D-Minn.) and Susan Collins (R-Maine) announced that their bipartisan bill to improve research, prevention, diagnostics, and treatment for tick-borne diseases was included in the government spending agreement released yesterday. Once passed by both the House and Senate, the bill will proceed to the President’s desk to be signed into law.
The Kay Hagan Tick Act unites the effort to confront the alarming public health threat posed by Lyme disease and other tick-borne diseases, which have risen exponentially from approximately 30,000 cases in 2003 to an estimated 450,000 last year. Sens. Smith and Collins renamed the bill in honor of former Senator Kay Hagan, who passed away in October due to complications from the tick-borne disease known as the Powassan virus.
“I’ve said that for the sake of Americans’ health and well-being, we need to move this bill forward. My hope is that our bipartisan bill quickly passes the House and Senate so it can go to the President’s desk and be signed into law,” said Sen. Smith. “The number of Lyme disease cases is on the rise, and we need to address this so Minnesotans can continue to enjoy spending time outside exploring our parks, swimming and boating in our lakes, and hiking in our forests safely.”
“The inclusion of the Tick Act in the appropriations agreement is a major victory for the hundreds of thousands of Americans who contract Lyme and other tick-borne illnesses each year. I am grateful for the countless advocates who shared their struggles with these diseases and conveyed the urgent need for this comprehensive, bipartisan bill,” said Sen. Collins. “With a national effort the TICK Act would establish, we can stop the spread of these devastating tick-borne illnesses and protect our health.”
“I was misdiagnosed by 23 doctors and specialists to the tune of $250,000 before getting an official diagnosis and proper treatment,” said Paula Jackson Jones, President and Co-Founder of Midcoast Lyme Disease Support & Education. “Enacting the Tick Act that Senator Collins introduced will provide a lifeline not only to patients but to medical providers. With funding available for research and education, we can get medical providers on the same page not only with improved diagnostic tools but better, more effective treatment options for their patients. With the Tick Act, and Senator Collins’ support in Washington, we can stem the growing threat of tick-borne disease.”
“Lyme is a frustrating and debilitating disease, but it’s a problem we can solve,” said Bonnie Crater, co-founder and board member at Center for Lyme Action. “What is needed is dedicated and sustained effort by the federal government to address this growing public health threat. The Kay Hagan Tick Act is a wonderful first step and is supported by more than 150 Lyme foundations and associations around the United States.”
Far too many Americans with Lyme disease experience a complex diagnostic odyssey that takes months or even years, while suffering severe and debilitating symptoms. In addition to the physical and emotional toll that Lyme disease takes, it is also expensive. Medical costs of Lyme disease are estimated at $1.3 billion per year. When accounting for indirect medical costs, including loss of work, the annual costs balloon to $75 billion per year.
Using a three-pronged approach, the Tick Act would:
1. Require the Department of Health and Human Services (HHS) to develop a National Strategy. This would help expand research, improve testing and treatment, and coordinate common efforts with DOD, USDA, EPA, the VA, and the Departments of Interior and Homeland Security.
2. Reauthorize Regional Centers of Excellence in Vector-Borne Disease for five years at $10 million per year. Funding for these centers, which was allotted in 2017, expires in 2021. These Centers have led the scientific response against tick-borne diseases, which now make up 75 percent of vector-borne diseases in the U.S. There are five centers located at universities in New York, California, Florida, Texas, and Wisconsin.
3. Authorize CDC Grants at $20 million per year that would be awarded to State Health Departments to improve data collection and analysis, support early detection and diagnosis, improve treatment, and raise awareness. These awards would help states build a public health infrastructure for Lyme and other tick and vector-borne diseases and amplify their initiatives through public-private partnerships.
The Tick Act is supported by more than 155 organizations, including the Center for Lyme Action, the Entomological Society of America, National Association of Vector-Borne Disease Control Officials, the National Association of County and City Health Officials, Midcoast Lyme Disease Support & Education Organization in Maine, the Northeast Regional Center for Excellence in Vector Borne Diseases, the LivLyme Foundation, the Global Lyme Alliance, and The Avril Lavigne Foundation.
Sens. Smith and Collins’ Tick Act is cosponsored by 31 of their Senate colleagues including Sens. Shelley Moore Capito (R-W.V.), Richard Blumenthal (D-Conn.), Cindy Hyde-Smith (R- Miss.), Christopher Murphy (D-Conn.), John Boozman (R-Ark.), Margaret Hassan (D-N.H.), Angus King (I-Maine), Mike Braun (R-Ind.), Bernie Sanders (I-Vt.), Cory Gardner (R-Colo.), Diane Feinstein (D-Calif), Thom Tillis (R-N.C.), Elizabeth Warren (D-Mass.), Richard Burr (R-N.C.), Chuck Schumer (D-N.Y.), Johnny Isakson (R-Ga.), Patty Murray (D-Wash.), Kirsten Gillibrand (D-N.Y.), Tammy Baldwin (D-Wis.), Jeanne Shaheen (D-N.H.), Bob Menendez (D-N.J.), Josh Hawley (R-Mo.), Tom Cotton (R-Ark.), Debbie Stabenow (D-Mich.), Bill Cassidy (R-La.), Bob Casey (D-Pa.), Michael Bennet (D-Colo.), and Gary Peters (D-Mich.).
English